256 results  1 of 13 

1 Pembrolizumab-Induced Nasal Polyposis: The First Reported Case
Justin M. Hintze, Holly Jones, Peter Lacy
J Rhinol.2023;30(2):125-128.   Published online 2023 July 28     DOI: http://dx.doi.org/10.18787/jr.2023.00022
      
2 Intrahepatic cholangiocarcinoma: Evolving role of neoadjuvant and targeted therapy
Michael Ghio, Adarsh Vijay
Ann Hepatobiliary Pancreat Surg.2023;27(2):123-130.   Published online 2023 February 24     DOI: http://dx.doi.org/10.14701/ahbps.22-110
      
3 Genomic and Transcriptomic Characterization Revealed the High Sensitivity of Targeted Therapy and Immunotherapy in a Subset of Endometrial Stromal Sarcoma
Nan Kang, Yinli Zhang, Shichao Guo, Ran Chen, Fangzhou Kong, Shuchun Wang, Mingming Yuan, Rongrong Chen, Danhua Shen, Jianliu Wang
Cancer Res Treat.2023;55(3):978-991.   Published online 2023 February 2     DOI: http://dx.doi.org/10.4143/crt.2022.1647
      
4 Advanced T and Natural Killer Cell Therapy for Glioblastoma
Wan-Soo Yoon, Dong-Sup Chung
J Korean Neurosurg Soc.2023;66(4):356-381.   Published online 2023 January 2     DOI: http://dx.doi.org/10.3340/jkns.2022.0267
      
5 Successful treatment of post–COVID-19 acute disseminated encephalomyelitis with urgent immunotherapy and neurointensive management: a case report
Jung Seok Lee, Hong Jun Kim, Joong-Goo Kim
J Neurocrit Care.2022;15(2):131-135.   Published online 2022 December 19     DOI: http://dx.doi.org/10.18700/jnc.220078
      
6 Ex Vivo Expansion of Highly Cytotoxic Natural Killer Cells Using Optimal Culture Medium
Seokho Kim
Ann Lab Med.2022;42(6):619-620.   Published online 2022 November 1     DOI: http://dx.doi.org/10.3343/alm.2022.42.6.619
      
7 Neoadjuvant Immunotherapy Following Definitive Surgical Treatment for Locoregionally Advanced Head and Neck Cancer: Perioperative Complication and Surgical Outcomes
Ju Ha Park, Young Min Park, Da Hee Kim, Se-Heon Kim, Hye Ryun Kim, Yoon Woo Koh
Korean J Otorhinolaryngol-Head Neck Surg.2022;65(10):610-616.   Published online 2022 October 17     DOI: http://dx.doi.org/10.3342/kjorl-hns.2022.00283
      
8 Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder
Hongsik Kim, Byong Chang Jeong, Joohyun Hong, Ghee Young Kwon, Chan Kyo Kim, Won Park, Hongryull Pyo, Wan Song, Hyun Hwan Sung, Jung Yong Hong, Se Hoon Park
Cancer Res Treat.2023;55(2):636-642.   Published online 2022 October 6     DOI: http://dx.doi.org/10.4143/crt.2022.343
      
9 Cytomegalovirus-Specific Immunotherapy for Glioblastoma Treatments
Jaehyun Ahn, Christopher Shin, Yeo Song Kim, Jae-Sung Park, Sin-Soo Jeun, Stephen Ahn
Brain Tumor Res Treat.2022;10(3):135-143.   Published online 2022 July 28     DOI: http://dx.doi.org/10.14791/btrt.2022.0010
      
10 Combined Treatment With Radiotherapy and Immunotherapy for Isocitrate Dehydrogenase Mutant Brainstem Glioma in Adult: A Case Report
Takayuki Morimoto, Ryosuke Matsuda, Tsutomu Nakazawa, Fumihiko Nishimura, Ichiro Nakagawa
Brain Tumor Res Treat.2022;10(2):129-133.   Published online 2022 April 29     DOI: http://dx.doi.org/10.14791/btrt.2022.0009
      
11 Combination of interventional oncology local therapies and immunotherapy for the treatment of hepatocellular carcinoma
Dong-Hyun Kim
J Liver Cancer.2022;22(2):93-102.   Published online 2022 April 22     DOI: http://dx.doi.org/10.17998/jlc.2022.03.28
      
12 Current Immunotherapeutic Approaches for Malignant Gliomas
Myung-Hoon Han, Choong Hyun Kim
Brain Tumor Res Treat.2022;10(1):1-11.   Published online 2022 January 28     DOI: http://dx.doi.org/10.14791/btrt.2022.10.e25
      
13 Genomic Sequencing for Bladder Urothelial Carcinoma and Its Clinical Implications for Immunotherapy
Ryul Kim, Jung Yong Hong, Jeeyun Lee, Ghee Young Kwon, Byong Chang Jeong, Se Hoon Park
Cancer Res Treat.2022;54(3):894-906.   Published online 2021 November 17     DOI: http://dx.doi.org/10.4143/crt.2021.854
      
14 Programmed death-ligand 1 expression and tumor-infiltrating lymphocytes in non-small cell lung cancer: association with clinicopathologic parameters
Gaurav Garg, Kuruswamy Thurai Prasad, Navneet Singh, Parul Gupta, Valliappan Muthu, Ashim Das, Amanjit Bal
J Pathol Transl Med.2021;55(6):398-405.   Published online 2021 October 6     DOI: http://dx.doi.org/10.4132/jptm.2021.08.08
      
15 Systemic therapy for advanced hepatocellular carcinoma: consideration for selecting second-line treatment
Bo Hyun Kim, Joong-Won Park
J Liver Cancer.2021;21(2):124-138.   Published online 2021 September 30     DOI: http://dx.doi.org/10.17998/jlc.2021.09.23
      
16 Advances in immune checkpoint inhibitors for hepatocellular carcinoma
Ji Won Han, Su-Hyung Park
J Liver Cancer.2021;21(2):139-145.   Published online 2021 September 30     DOI: http://dx.doi.org/10.17998/jlc.2021.09.24
      
17 An update on immunotherapy with PD-1 and PD-L1 blockade
Sung Ae Koh
Yeungnam Univ J Med.2021;38(4):308-317.   Published online 2021 September 9     DOI: http://dx.doi.org/10.12701/yujm.2021.01312
      
18 Cost-Effectiveness Analysis of Immunotherapy in Patient with Allergic Rhinitis
Joon Yong Park, Yoon-Sook Kim, Jin Kook Kim, Jae Hoon Cho
Korean J Otorhinolaryngol-Head Neck Surg.2021;64(8):554-562.   Published online 2021 August 26     DOI: http://dx.doi.org/10.3342/kjorl-hns.2020.00752
      
19 Engineering a High-Affinity PD-1 Peptide for Optimized Immune Cell–Mediated Tumor Therapy
Yilei Chen, Hongxing Huang, Yin Liu, Zhanghao Wang, Lili Wang, Quanxiao Wang, Yan Zhang, Hua Wang
Cancer Res Treat.2022;54(2):362-374.   Published online 2021 August 3     DOI: http://dx.doi.org/10.4143/crt.2021.424
      
20 Clinicopathologic Characteristics and Clinical Outcome of Localized Liposarcoma: A Single-Center Experience over 25 Years and Evaluation of PD-L1 Expression
Heejung Chae, Jeong Eun Kim, Wanlim Kim, Jong-Seok Lee, Si Yeol Song, Min Hee Lee, Hye Won Chung, Kyung-Ja Cho, Joon Seon Song, Jin-Hee Ahn
Cancer Res Treat.2022;54(2):579-589.   Published online 2021 July 6     DOI: http://dx.doi.org/10.4143/crt.2021.496
      

 1 of 13